A detailed history of Bessemer Group Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bessemer Group Inc holds 26,840 shares of JAZZ stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,840
Previous 101 26474.26%
Holding current value
$3.34 Million
Previous $11,000 27090.91%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.57 - $116.37 $2.69 Million - $3.11 Million
26,739 Added 26474.26%
26,840 $2.99 Million
Q2 2024

Aug 13, 2024

BUY
$103.94 - $118.98 $4,261 - $4,878
41 Added 68.33%
101 $11,000
Q1 2024

May 13, 2024

SELL
$115.19 - $132.77 $450,392 - $519,130
-3,910 Reduced 98.49%
60 $8,000
Q4 2023

Feb 09, 2024

SELL
$114.26 - $136.0 $45,589 - $54,264
-399 Reduced 9.13%
3,970 $488,000
Q3 2023

Nov 13, 2023

SELL
$122.0 - $145.31 $4,392 - $5,231
-36 Reduced 0.82%
4,369 $565,000
Q2 2023

Aug 10, 2023

BUY
$122.5 - $147.16 $4,287 - $5,150
35 Added 0.8%
4,405 $545,000
Q1 2023

May 10, 2023

BUY
$133.98 - $160.47 $133 - $160
1 Added 0.02%
4,370 $639,000
Q4 2022

Feb 13, 2023

BUY
$129.72 - $159.85 $7,004 - $8,631
54 Added 1.25%
4,369 $696,000
Q3 2022

Nov 09, 2022

BUY
$126.59 - $161.18 $29,495 - $37,554
233 Added 5.71%
4,315 $575,000
Q2 2022

Aug 10, 2022

SELL
$141.59 - $168.66 $28,601 - $34,069
-202 Reduced 4.72%
4,082 $637,000
Q1 2022

May 12, 2022

BUY
$129.64 - $160.7 $162,179 - $201,035
1,251 Added 41.25%
4,284 $667,000
Q4 2021

Jan 27, 2022

BUY
$119.87 - $145.67 $113,516 - $137,949
947 Added 45.4%
3,033 $386,000
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $3,215 - $4,619
25 Added 1.21%
2,086 $272,000
Q2 2021

Aug 06, 2021

SELL
$160.2 - $186.42 $54,628 - $63,569
-341 Reduced 14.2%
2,061 $366,000
Q1 2021

May 13, 2021

BUY
$150.19 - $173.5 $73,593 - $85,015
490 Added 25.63%
2,402 $394,000
Q4 2020

Feb 09, 2021

BUY
$140.71 - $165.05 $22,372 - $26,242
159 Added 9.07%
1,912 $316,000
Q3 2020

Nov 12, 2020

BUY
$105.46 - $144.13 $184,871 - $252,659
1,753 New
1,753 $250,000
Q2 2019

Jul 19, 2019

SELL
$125.55 - $144.48 $878 - $1,011
-7 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$121.81 - $142.95 $1,339 - $1,572
-11 Reduced 61.11%
7 $1,000
Q3 2018

Nov 06, 2018

BUY
$161.01 - $180.57 $2,898 - $3,250
18 New
18 $3,000
Q1 2018

May 10, 2018

SELL
$135.59 - $157.16 $10,982 - $12,729
-81 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$142.62 - $155.6 $11,552 - $12,603
81
81 $12,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.